Last update :
19/11/2024
Anticancer drug   Brentuximab vedotin  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adcetris Argentina, Australia, Belgium, Brazil, Canada, Chile, Denmark, Ecuador, Germany, Great Britain, Hungary, Ireland, Italy, Japan, Luxembourg, Malaysia, Mexico, Norway, Peru, Romania, Slovenia, Spain, Sweden, Switzerland, Turkey, United States of America
Stability in solutions   injection   Stability in solutions : Brentuximab vedotin     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for Injection 5 mg/ml 2-8°C Protect from light
24 Hour
3495
Manufacturer's stability data

Not specified NaCl 0,9% or Glucose 5% 0,4 >> 1,2 mg/ml 2-8°C Protect from light
24 Hour
3495
Manufacturer's stability data

Not specified Ringer’s lactate solution 0,4 >> 1,2 mg/ml 2-8°C Protect from light
24 Hour
3495
Manufacturer's stability data


  Mentions Légales